Selank reconstitution calculator
- Concentration
- 2.5 mg/mL
- Doses per vial
- 16
- Weeks (1 dose/wk)
- 16
12 units (0.12 mL) on a 1 mL U-100 syringe: 300 mcg from a 5 mg vial + 2 mL water (Selank).
Dosing table for a 5 mg vial
Syringe units (U-100) for each dose, by how much bacteriostatic water you add.
| Dose | 1 mL water | 2 mL water | 2.5 mL water | 3 mL water |
|---|---|---|---|---|
| 100 mcg | 2 | 4 | 5 | 6 |
| 250 mcg | 5 | 10 | 12.5 | 15 |
| 300 mcg | 6 | 12 | 15 | 18 |
| 500 mcg | 10 | 20 | 25 | 30 |
| 750 mcg | 15 | 30 | 37.5 | 45 |
| 1000 mcg | 20 | 40 | 50 | 60 |
How the math works
Concentration is the vial's milligrams divided by the water you add. Volume to draw is your dose divided by that concentration. On a U-100 syringe, 1 mL is 100 units, so units = mL × 100.
300 mcg = 0.3 mg; 0.3 mg ÷ 2.5 mg/mL = 0.12 mL
0.12 mL × 100 = 12 units
How many units is 300 mcg of Selank?
With a 5 mg vial and 2 mL of bacteriostatic water, 300 mcg is 12 units (0.12 mL) on a U-100 syringe. With 1 mL of water it is 6 units. The answer always depends on how much water was added.
How much bacteriostatic water for a 5 mg Selank vial?
The water only sets the concentration; the amount of Selank in the vial stays the same. 2 mL makes 2.5 mg/mL, so 300 mcg is 12 units. 2.5 mL makes 2 mg/mL, so the same 300 mcg is 15 units. More water makes small doses easier to measure but needs more volume per injection.
How many 300 mcg doses are in a 5 mg vial?
5 mg is 5,000 mcg; 5,000 ÷ 300 = 16.67, so 16 full doses of 300 mcg. Any liquid lost in the needle and vial is not counted.
How to reconstitute Selank?
No label exists. At 1 mL a 5 mg vial is 5 mg/mL; at 2 mL it is 2.5 mg/mL; at 4 mL it is 1.25 mg/mL.
Calculated from vial mg 5; water m L 1, 2, 4. Formula: 5/1 = 5; 5/2 = 2.5; 5/4 = 1.25 mg/mL
How much bac water for Selank?
The water volume only sets the strength. For a 10 mg Selank vial, 2 mL gives 5 mg/mL, 4 mL gives 2.5 mg/mL and 10 mL gives 1 mg/mL.
Calculated from vial mg 10; water m L 2, 4, 10. Formula: 10/2 = 5; 10/4 = 2.5; 10/10 = 1 mg/mL
Preset doses are round numbers for the arithmetic, not dosing guidance. Vial sizes are the ones most often mentioned for Selank in community discussions.
Selank doses in the abstracts are rodent figures, per kilogram
In rats, high doses of 1000-2000 microg/kg after repeated injection counteracted depression-like behaviour; this was an animal result.[3]
In mice, low doses of 100 and 300 microg/kg reduced immobility in the forced swimming test after a single injection but not after repeated injection.[3]
A mouse study compared intraperitoneal and intranasal selank at 300 μg/kg/day for 5 days.[4]
Human trials of selank in anxiety disorders exist, but the abstracts on file give efficacy and tolerability without a mass or volume per dose.[5]
Vial arithmetic with no trial dose to anchor it
For a 5 mg vial mixed with 2 mL (2.5 mg/mL) each U-100 unit is 0.025 mg, or 25 mcg; for a 10 mg vial in 2 mL (5 mg/mL) it is 50 mcg.
Calculated from vials mg 5, water m L 2; mg 10, water m L 2. Formula: 5/2 = 2.5 mg/mL x 0.01 = 0.025 mg; 10/2 = 5 mg/mL x 0.01 = 0.05 mg
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3[Effects of heptapeptide selank on genetically-based and situation-provoked symptoms of depression in behavior in WAG/Rij and Wistar rats, and in BALB/c mice].Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova · 2008PMID 18661785Accessed 2 Oct 2026
- 4[COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6 MICE.].Eksperimental'naia i klinicheskaia farmakologiia · 2016PMID 29787664Accessed 2 Oct 2026
- 5[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014PMID 25176261Accessed 2 Oct 2026
Found an error? Report a correction.